Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents.
Guasch M, Cañete F, Ordás I, Iglesias-Flores E, Clos A, Gisbert JP, Taxonera C, Vera I, Mínguez M, Guardiola J, Rivero M, Nos P, Gomollón F, Barrio J, de Francisco R, López-Sanromán A, Martín-Arranz MD, Garcia-Planella E, Camargo R, García-López S, de Castro L, Calvet X, Esteve M, Mañosa M, Domènech E; GETECCU-ENEIDA registry. Guasch M, et al. Among authors: ordas i. J Gastroenterol Hepatol. 2020 Dec;35(12):2080-2087. doi: 10.1111/jgh.15084. Epub 2020 May 10. J Gastroenterol Hepatol. 2020. PMID: 32350906 Free article.
Impact of mass screening for gluten-sensitive enteropathy in working population.
Mariné M, Fernández-Bañares F, Alsina M, Farré C, Cortijo M, Santaolalla R, Salas A, Tomàs M, Abugattas E, Loras C, Ordás I, Viver JM, Esteve M. Mariné M, et al. Among authors: ordas i. World J Gastroenterol. 2009 Mar 21;15(11):1331-8. doi: 10.3748/wjg.15.1331. World J Gastroenterol. 2009. PMID: 19294762 Free PMC article.
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.
Loras C, Gisbert JP, Mínguez M, Merino O, Bujanda L, Saro C, Domenech E, Barrio J, Andreu M, Ordás I, Vida L, Bastida G, González-Huix F, Piqueras M, Ginard D, Calvet X, Gutiérrez A, Abad A, Torres M, Panés J, Chaparro M, Pascual I, Rodriguez-Carballeira M, Fernández-Bañares F, Viver JM, Esteve M; REPENTINA study; GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa) Group. Loras C, et al. Among authors: ordas i. Gut. 2010 Oct;59(10):1340-6. doi: 10.1136/gut.2010.208413. Epub 2010 Jun 24. Gut. 2010. PMID: 20577000
Epidemiological risk factors in microscopic colitis: a prospective case-control study.
Fernández-Bañares F, de Sousa MR, Salas A, Beltrán B, Piqueras M, Iglesias E, Gisbert JP, Lobo B, Puig-Diví V, García-Planella E, Ordás I, Andreu M, Calvo M, Montoro M, Esteve M, Viver JM; RECOMINA Project, GETECCU Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa. Fernández-Bañares F, et al. Among authors: ordas i. Inflamm Bowel Dis. 2013 Feb;19(2):411-7. doi: 10.1002/ibd.23009. Inflamm Bowel Dis. 2013. PMID: 23344243
Impact of current smoking on the clinical course of microscopic colitis.
Fernández-Bañares F, de Sousa MR, Salas A, Beltrán B, Piqueras M, Iglesias E, Gisbert JP, Lobo B, Puig-Diví V, García-Planella E, Ordás I, Andreu M, Calvo M, Montoro M, Esteve M, Viver JM; RECOMINA Project, GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa). Fernández-Bañares F, et al. Among authors: ordas i. Inflamm Bowel Dis. 2013 Jun;19(7):1470-6. doi: 10.1097/MIB.0b013e318281f3cc. Inflamm Bowel Dis. 2013. PMID: 23552765
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients.
Chaparro M, Ordás I, Cabré E, Garcia-Sanchez V, Bastida G, Peñalva M, Gomollón F, García-Planella E, Merino O, Gutiérrez A, Esteve M, Márquez L, Garcia-Sepulcre M, Hinojosa J, Vera I, Muñoz F, Mendoza JL, Cabriada JL, Montoro MA, Barreiro-de Acosta M, Ceña G, Saro C, Aldeguer X, Barrio J, Maté J, Gisbert JP. Chaparro M, et al. Among authors: ordas i. Inflamm Bowel Dis. 2013 Jun;19(7):1404-10. doi: 10.1097/MIB.0b013e318281f28f. Inflamm Bowel Dis. 2013. PMID: 23665964
Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3).
Loras C, Gisbert JP, Saro MC, Piqueras M, Sánchez-Montes C, Barrio J, Ordás I, Montserrat A, Ferreiro R, Zabana Y, Chaparro M, Fernández-Bañares F, Esteve M; REPENTINA study, GETECCU group (Grupo Español de trabajo de Enfermedades de Crohn y Colitis Ulcerosa). Loras C, et al. Among authors: ordas i. J Crohns Colitis. 2014 Nov;8(11):1529-38. doi: 10.1016/j.crohns.2014.06.009. Epub 2014 Jul 19. J Crohns Colitis. 2014. PMID: 25052345
90 results